HLA-G is a molecule that was first known to confer protection to the fetus from destruction by
the immune system of its mother, thus critically contributing to fetal–maternal tolerance. The …

While infection with Epstein–Barr virus (EBV) is known to be an essential risk factor for the
development of nasopharyngeal carcinoma (NPC), other co-factors including genetic factors …

Squamous-cell cancer of the head and neck (SCCHN) represents a heterogeneous disease
entity, with various etiological factors implicated in the genesis of distinct molecular subsets …

Aberrant induction of human leukocyte antigen-G (HLA-G) expression has been observed in
various malignancies and is strongly associated with tumor immune escape, metastasis and …

The human leukocyte antigen (HLA)-G is a non-classical HLA class I molecule, which has
distinct features to classical HLA-A,-B,-C antigens, such as a low polymorphism, different …

Considering that the non-classical HLA-G molecule has well-recognized tolerogenic
properties, HLA-G expression is expected to be deleterious when present in tumor cells and …

Human leukocyte antigen-G (HLA-G) is a nonclassical major histocompatibility complex
(MHC) class I molecule involved in immune tolerance processes, playing an important role …

The interplay between host cell genetics and Epstein-Barr virus (EBV) infection contributes
to the development of nasopharyngeal carcinoma (NPC). Understanding the host genetic …

Human leukocyte antigen‑G (HLA‑G) is a non‑classical HLA molecule, predominantly
expressed in cytotrophoblast cells to protect the fetus during pregnancy. Notably, a high …

Background The mere presence of human papillomavirus (HPV) is not enough for cervical
cancer development and immunogenetic background may play an important role. Human …